Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons

Psychopharmacology

Volumn 231, Issue 6, 2014, Pages 1105-1124

  Dage, Jeffrey L ^a   Colvin, Ellen M ^a   Fouillet, Antoine ^a   Langron, Emily ^a   Roell, William C ^a   Li, Jingling ^a   Mathur, Sachin X ^a   Mogg, Adrian J ^a   Schmitt, Matthew G ^a   Felder, Christian C ^a   Merchant, Kalpana M ^a   Isaac, John ^a   Broad, Lisa M ^a   Sher, Emanuele ^a   Ursu, Daniel ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

GABAA receptors; Glutamate receptors; Ion channels; IPSC; Stem cells

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; IONOTROPIC RECEPTOR; LIGAND GATED ION CHANNEL; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; ARTICLE; AUTISM; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; FOREBRAIN; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE CELL MEMBRANE STEADY POTENTIAL; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNAPTIC POTENTIAL; UPREGULATION;

CALCIUM; CALCIUM CHANNELS; GENE EXPRESSION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ION CHANNELS; MEMBRANE POTENTIALS; NEURONS; PROSENCEPHALON; RECEPTORS, GABA; RECEPTORS, GABA-A; RECEPTORS, IONOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; TIME FACTORS; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84896711407     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3384-2     Document Type: Article

References (71)

1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F et al (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276-1284
2. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M et al (2013) NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 41:D991-D995
3. Basu SN, Kollu R, Banerjee-Basu S (2009) AutDB: a gene reference resource for autism research. Nucleic Acids Res 37:D832-D836
4. Baumbarger PJ, Muhlhauser M, Zhai J, Yang CR, Nisenbaum ES (2001) Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator. J Pharmacol Exp Ther 298:86-102 (Pubitemid 32574514)
5. Bellone C, Nicoll RA (2007) Rapid bidirectional switching of synaptic NMDA receptors. Neuron 55:779-785 (Pubitemid 47321083)
6. Bettini E, Sava A, Griffante C, Carignani C, Buson A, Capelli AM et al (2010) Identification and characterization of novel NMDA receptor antagonists selective for. J Pharmacol Exp Ther 335:636-644
7. Chai X, Dage JL, Citron M (2012) Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol Dis 48:356-366
8. - cotransporter expression in rat neocortex. Brain Res Dev Brain Res 109:281-292
9. Cliff C, Stankewicz C, Chase LG, Feng X, George M, Grinager J et al (2011) Human-based systems for in vitro modeling: the development and characterization of induced pluripotent stem cell (iPSC)-derived neurons for preclinical use. 17th Annual Society for Biomolecular Screening Conference and Exhibition, Orlando, FL, USA. Ref Type: Conference Proceeding
10. Colvin EM, Mogg AJ, Langron E, Findlay JD, Dage JL, Broad LM et al (2012) Pharmacological characterisation of native rat and human NMDA receptors. 8th FENS Forum of Neuroscience. Ref Type: Conference Proceeding
11. Courchesne E, Mouton PR, CalhounME, Semendeferi K, Hrens-Barbeau C, Hallet MJ et al (2011) Neuron number and size in prefrontal cortex of children with autism. JAMA 306:2001-2010
12. Coyne L, Shan M, Przyborski SA, Hirakawa R, Halliwell RF (2011) Neuropharmacological properties of neurons derived from human stem cells. Neurochem Int 59:404-412
13. Dai WM, Egebjerg J, Lambert JD (2001) Characteristics of AMPA receptor-mediated responses of cultured cortical and spinal cord neurones and their correlation to the expression of glutamate receptor subunits, GluR1-4. Br J Pharmacol 132:1859-1875 (Pubitemid 32397979)
14. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG et al (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33:e175
15. Dai G, Haedo RJ, Warren VA, Ratliff KS, Bugianesi RM, Rush A et al (2008) A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors. Assay Drug Dev Technol 6:195-212 (Pubitemid 351670382)
16. DeLorey TM, Sahbaie P, Hashemi E, Homanics GE, Clark JD (2008) Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav Brain Res 187:207-220
17. DeRosa BA, Van Baaren JM, Dubey GK, Lee JM, Cuccaro ML, Vance JM et al (2012) Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells. Neurosci Lett 516:9-14
18. Diboun I, Wernisch L, Orengo CA, Koltzenburg M (2006) Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 7:252
19. Dodla MC, Mumaw J, Stice SL (2010) Role of astrocytes, soluble factors, cells adhesion molecules and neurotrophins in functional synapse formation: implications for human embryonic stem cell derived neurons. Curr Stem Cell Res Ther 5:251-260
20. Dolmetsch R, Geschwind DH (2011) The human brain in a dish: the promise of iPSC-derived neurons. Cell 145:831-834
21. Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA et al (2005) NKCC1 transporter facilitates seizures in the developing brain. Nat Med 11:1205-1213 (Pubitemid 43093668)
22. Edman S, McKay S, Macdonald LJ, Samadi M, Livesey MR, Hardingham GE et al (2012) TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner. Neuropharmacology 63:441-449
23. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T et al (2012) Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med 4:145ra104
24. Fischer W, Franke H, Scheibler P, Allgaier C, Illes P (2002) AMPA-induced Ca (2+) influx in cultured rat cortical nonpyramidal neurones: pharmacological characterization using fura-2 microfluorimetry. Eur J Pharmacol 438:53-62 (Pubitemid 34245435)
25. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
26. Gill JK, Chatzidaki A, Ursu D, Sher E, Millar NS (2013) Contrasting properties of alpha7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors. PLoS One 8: e55047
27. Goldberg MC, Spinelli S, Joel S, Pekar JJ, Denckla MB, Mostofsky SH (2011) Children with high functioning autism show increased prefrontal and temporal cortex activity during error monitoring. Dev Cogn Neurosci 1:47-56
28. Grskovic M, Javaherian A, Strulovici B, Daley GQ (2011) Induced pluripotent stem cells - opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 10:915-929
29. Gupta K, Chandran S, Hardingham GE (2013) Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration. Br J Clin Pharmacol 75:907-918
30. Haythornthwaite A, Stoelzle S, Hasler A, Kiss A, Mosbacher J, George M et al (2012) Characterizing human ion channels in induced pluripotent stem cell-derived neurons. J Biomol Screen 17:1264-1272
31. Heikkila TJ, Yla-Outinen L, Tanskanen JM, Lappalainen RS, Skottman H, Suuronen R et al (2009) Human embryonic stem cell-derived neuronal cells formspontaneously active neuronal networks in vitro. Exp Neurol 218:109-116
32. Hotta A, Cheung AY, Farra N, Vijayaragavan K, Seguin CA, Draper JS et al (2009) Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 6:370-376
33. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264
34. Karumbayaram S, Lee P, Azghadi SF, Cooper AR, Patterson M, Kohn DB et al (2012) From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols. Stem Cells Transl Med 1:36-43
35. Kauffmann A, Gentleman R, Huber W (2009) arrayQualityMetrics - a bioconductor package for quality assessment of microarray data. Bioinformatics 25:415-416
36. Krey JF, Pasca SP, Shcheglovitov A, Yazawa M, Schwemberger R, Rasmusson R et al (2012) Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat Neurosci 16:201-209
37. Kumar RA, Christian SL (2009) Genetics of autism spectrum disorders. Curr Neurol Neurosci Rep 9:188-197
38. Lee H, Chen CX, Liu YJ, Aizenman E, Kandler K (2005) KCC2 expression in immature rat cortical neurons is sufficient to switch the polarity of GABA responses. Eur J Neurosci 21:2593-2599 (Pubitemid 40813941)
39. Leek JT, Storey JD (2007) Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 3:1724-1735 (Pubitemid 47510264)
40. Luhmann HJ, Prince DA (1991) Postnatal maturation of the GABAergic system in rat neocortex. J Neurophysiol 65:247-263
41. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K (2008) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3:340-345
42. Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y et al (2010) A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143:527-539
43. Mariani J, Simonini MV, Palejev D, Tomasini L, Coppola G, Szekely AM et al (2012) Modeling human cortical development in vitro using induced pluripotent stem cells. Proc Natl Acad Sci U S A 109: 12770-12775
44. McKay S, Griffiths NH, Butters PA, Thubron EB, Hardingham GE, Wyllie DJ (2012) Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist. Br J Pharmacol 166:924-937
45. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E et al (2009) Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14: 252-260
46. Muhle R, Trentacoste SV, Rapin I (2004) The genetics of autism. Pediatrics 113:e472-e486
47. Murphy D, SpoorenW(2012) EU-AIMS: a boost to autism research. Nat Rev Drug Discov 11:815-816
48. Murphy TH, Blatter LA, Wier WG, Baraban JM (1992) Spontaneous synchronous synaptic calcium transients in cultured cortical neurons. J Neurosci 12:4834-4845
49. Nyegaard M, Demontis D, Foldager L, Hedemand A, Flint TJ, Sorensen KM et al (2010) CACNA1C (rs1006737) is associated with schizophrenia. Mol Psychiatry 15:119-121
50. Ogden KK, Traynelis SF (2011) New advances in NMDA receptor pharmacology. Trends Pharmacol Sci 32:726-733
51. Owens DF, Boyce LH, Davis MB, Kriegstein AR (1996) Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging. J Neurosci 16:6414-6423 (Pubitemid 26337365)
52. Paoletti P, Neyton J (2007) NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 7:39-47 (Pubitemid 46238036)
53. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A et al (2008) Disease-specific induced pluripotent stem cells. Cell 134: 877-886
54. Pasca SP, Portmann T, Voineagu I, Yazawa M, Shcheglovitov A, Pasca AM et al (2011) Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med 17:1657-1662
55. Petit I, Kesner NS, Karry R, Robicsek O, Aberdam E, Muller FJ et al (2012) Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders. Stem Cell Res 8:134-140
56. Piccolo SR, Sun Y, Campbell JD, Lenburg ME, Bild AH, Johnson WE (2012) A single-sample microarray normalization method to facilitate personalized- medicine workflows. Genomics 100:337-344
57. Robinson HP, KawaharaM, Jimbo Y, Torimitsu K, Kuroda Y, Kawana A (1993) Periodic synchronized bursting and intracellular calcium transients elicited by low magnesium in cultured cortical neurons. J Neurophysiol 70:1606-1616 (Pubitemid 23326396)
58. Ruel J, Guitton MJ, Puell JL (2002) Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist. CNS Drug Rev 8:235-254 (Pubitemid 35191285)
59. Sanger H, Hanna L, Colvin EM, Grubisha O, Ursu D, Heinz BA et al (2013) Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR. Neuropharmacology 66:264-273
60. Sanz-Clemente A, Matta JA, Isaac JT, Roche KW (2010) Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors. Neuron 67:984-996
61. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550 (Pubitemid 41528093)
62. Tseng GC, Ghosh D, Feingold E (2012) Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic Acids Res 40:3785-3799
63. Vaccarino FM, Stevens HE, Kocabas A, Palejev D, Szekely A, Grigorenko EL et al (2011) Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders. Neuropharmacology 60:1355-1363
64. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS et al (2009) Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459:528-533
65. Weick JP, Liu Y, Zhang SC (2011) Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural network. Proc Natl Acad Sci U S A 108: 20189-20194
66. Whitemarsh RC, Strathman MJ, Chase LG, Stankewicz C, Tepp WH, Johnson EA et al (2012) Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol Sci 126:426-435
67. Xu X, Lei Y, Luo J, Wang J, Zhang S, Yang XJ et al (2013) Prevention of beta-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events. Stem Cell Res 10:213-227
68. Ye ZY, Li L, Li DP, Pan HL (2012) Casein kinase 2-mediated synaptic GluN2A up-regulation increases N-methyl-D-aspartate receptor activity and excitability of hypothalamic neurons in hypertension. J Biol Chem 287:17438-17446
69. 2+ influx in developing neocortex by excitatory and inhibitory neurotransmitters. Neuron 6:333-344
70. Zhong J, Russell SL, Pritchett DB, Molinoff PB, Williams K (1994) Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol Pharmacol 45:846-853 (Pubitemid 24155774)
71. Zhong J, Carrozza DP, Williams K, Pritchett DB, Molinoff PB (1995) Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J Neurochem 64:531-539